Constrained spirocyclic compounds as CGRP receptor antagonists

Details for Australian Patent Application No. 2007332898 (hide)

Owner Merck & Co., Inc.

Inventors Selnick, Harold G.; Bell, Ian M.

Agent Spruson & Ferguson

Pub. Number AU-A-2007332898

PCT Pub. Number WO2008/073251

Priority 60/873,854 08.12.06 US

Filing date 5 December 2007

Wipo publication date 19 June 2008

International Classifications

A61K 31/415 (2006.01) - 1,2-Diazoles

Event Publications

18 June 2009 PCT application entered the National Phase

  PCT publication WO2008/073251 Priority application(s): WO2008/073251

21 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

15 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007332902-Spreading layer and humidity control layer for enhancing sensor performance

2007332878-Means for the treatment of acute and chronic disorders of cerebral circulation, including insult, based on hydrogenated pyrido (4, 3-b) indoles (variants), pharmacological means based thereon and method for the use thereof